Morgan Stanley Capital Services LLC Rule 38.5- ALLERGAN PLC (3522M)
11 5월 2020 - 3:00PM
UK Regulatory
TIDM0Y7T
RNS Number : 3522M
Morgan Stanley Capital Services LLC
08 May 2020
FORM 38.5
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT,
1997, TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
1. KEY INFORMATION
Name of exempt market-maker Morgan Stanley Capital Services
LLC
Company dealt in ALLERGAN PLC
---------------------------------
Class of relevant security to US$0.0001 ORDINARY SHARES
which the dealings being disclosed
relate (Note 1)
---------------------------------
Date of dealing 07 MAY 2020
---------------------------------
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant Highest price paid Lowest price paid (Note
secuities accquired (Note 3) 3)
3,228,142 195.2700 USD 192.9600 USD
------------------- ------------------------
Total number of relevant Highest price paid Lowest price paid (Note
secuities disposed (Note 3) 3)
1,350,028 193.6300 USD 192.9900 USD
------------------- ------------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 4) securities
(Note 5)
CFD LONG 438 192.9900 USD
---------------------- ------------------- ---------------
CFD LONG 536,000 192.9900 USD
---------------------- ------------------- ---------------
CFD LONG 811,000 192.9900 USD
---------------------- ------------------- ---------------
CFD LONG 400 193.0525 USD
---------------------- ------------------- ---------------
CFD LONG 1,910 193.1474 USD
---------------------- ------------------- ---------------
CFD LONG 21 193.5461 USD
---------------------- ------------------- ---------------
CFD SHORT 808,600 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 576,600 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 648,100 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 400 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 698,400 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 462,800 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 10,000 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 5,000 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 5,000 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 7 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 5,000 192.9900 USD
---------------------- ------------------- ---------------
CFD SHORT 1,810 194.2061 USD
---------------------- ------------------- ---------------
(c) Options transactions in respect of existing relevant securities
i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type, e.g Expiry Option
name, eg selling, of securities Price American, Date money paid/received
call option purchasing, to which European per unit
varying the option etc (Note 3)
etc relates
(Note 5)
N/A N/A N/A N/A N/A N/A N/A
------------- --------------- --------- ----------- ------- ---------------------
(ii) Exercising
Product name, eg call Number of securities Exercise price per
option unit (Note 3)
N/A N/A N/A
--------------------- -------------------
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full Details of any agreement, arrangement or understanding between
the person disclosing and any other person relating to the voting
rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should
be stated.
Date of disclosure 11 MAY 2020
Contact Name Craig Horsley
-----------------
Telephone Number +44(141) 245 7736
-----------------
Name of offeree/offeror with ABBVIE INC.
which connected
-----------------
Nature of connection (Note 6) Advisory
-----------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEUWRRRRWUVRAR
(END) Dow Jones Newswires
May 11, 2020 02:00 ET (06:00 GMT)
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
